Funding from here is very problematic. The latest round will be well undersubscribed making the cost of the exercise and the dilutionary impact far more costly than the value in the money raised. We would be better served if they were able to show a path for survival rather than just the products we have. This might entice a few more investors and extend funding until we get some benefit from the term sheets. If the first commercial product comes in in 2028, I hope we have a plan to be still alive and kicking till then because that's a pretty long wait under trying circumstances. I'm only a small holder and will follow you in the capital raising debono primarily because it won't cost me much and it would be nice if one or more of the company's products made it onto the world stage. Secondly, if that were to happen, the potential gain given our miserly MC will be enormous.
1AD Price at posting:
0.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)